Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
4
×
boston blog main
boston top stories
life sciences
national blog main
national top stories
deals
gene therapy
national
new york blog main
new york top stories
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
startups
abbvie
acetylon pharmaceuticals
adverum biotechnologies
albert bourla
alzheimer's disease
ambys medicines
amgen
amicus therapeutics
arvinas
batten disease
bayer
biogen
boston
boulder/denver blog main
boulder/denver top stories
breast cancer
brian stuglik
cancer diagnostics
cancer immunotherapy
casimir trials
celenex
cell therapy
christine mcsherry
chuck schumer
What
future
4
×
today
4
×
boston
company
digital
new
patients
accelerating
acquisitions
aiming
albert
ambys
app
attend
based
big
biggest
bio
biofourmis
biopharma's
biopharma’s
biotech
bird
bourla
breakthrough
breakthroughs
ceo
closer
control
crispr
deadly
deal
debuted
designation
device
diseases
drug
early
ends
failure
Language
unset
unknown
Current search:
biotech
×
today
×
future
×
@techcrunch.com
2 years ago
Biofourmis receives FDA breakthrough device designation for heart failure “digital therapy”
@xconomy.com
4 years ago
Early Bird Sale Ends Today for Xcelerating Life Sciences Boston: Biopharma’s Future in Digital Health
@xconomy.com
4 years ago
Bio Roundup: Pfizer’s Future, CRISPR in Patients, Drug Imports & More
@xconomy.com
5 years ago
With Big Takeda Deal at Launch, Can Ambys Keep Control of Its Future?
